Company intelligence / Profile preview

Temad

Alborz/Tehran, Alborz, Iran

Ownership: Private
Employees: ~620
Development stage: Other

Overview

Temad is a leading Iranian producer of pharmaceutical active ingredients (APIs), especially for narcotic and non-narcotic drugs, supplying both bulk APIs and finished dosage forms to domestic and international markets. The company holds significant regional export leadership and is certified under international pharmaceutical quality and manufacturing standards[1][2][4].

Therapeutic areas: EndocrinologyMetabolic DisordersPsychiatryInfectious DiseasesPulmonologyCardiovascularOtherNeurology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Domestic and international pharmaceutical companies (for supply and export)

Beyond the preview

Go deeper on Temad.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Temad.

Explore the full profile